The I-Cube Lab aims to foster collaborations between healthcare professionals and scientists to pursue cancer research.

A data revolution is underway in modern biological science, now that obtaining the genome sequence has become routine and increasingly affordable. 

The Neural Coding Group has a broad interest in systems neuroscience spanning areas such as sensory coding, adaptation and behaviour.

We aim to understand complex molecular processes by which these transcription factors interact with signal transduction pathways, chromatin and RNA.

We are interested in how the mammalian brain processes sensory information received from the external world.

The Synaptic Mechanisms Laboratory investigates how individual synapses in the central nervous system function and how they are modulated.

A special interest of this group is in type 3 immune responses including the CD4 subset of inflammatory Th17 cells, neutrophils and dendritic cells.

By studying how bacteria resist to bacteriophage infection, our laboratory seeks to discover and engineer new CRISPR and RNA technologies.

In the Burr laboratory, we aim to uncover the molecular mechanisms by which cancer cells evade surveillance and control by the immune system.

The focus of our research is understanding how to generate effective immunity against the malaria parasite Plasmodium.

Our research focuses on understanding the causes of autoimmune diseases by investigating cytokine receptor signaling and nucleic acid sensors, aiming to develop targeted therapies.

The main focus of the lab is to investigate novel pathways regulating B cell development and function.

The Eyras Group is working to understand the biology of RNA and cancer using computational methods.

The Fischer lab investigates the connection between chromatin structure, pervasive transcription and RNA surveillance, and their influence on genomic stability.

The group investigates the molecular basis of processes coordinated by platelets across vascular biology.

Research group led by Dr Amee George.

This group focus on targeting the ribosome to treat disease including cancer and bone marrow disorders.

We are interested in learning gene expression control mechanisms through the lens of host-transposon interaction and how they play roles in animal development.

Identifying the genetic and cellular causes of immune mediated disease to personalise diagnosis and treatment.

Our group investigates how calcium channels and receptors affect the sensory processing in cortical neurons with the focus on detection and behaviour.

Discovering biological physics through optics, computing, materials and fluid dynamics.

The Trauma and Orthopaedic Research Unit (TORU) undertakes clinical and laboratory research in the field of orthopaedics.

Lipotek is a developer of targeted vaccine delivery and adjuvant technologies.

My interest in the optical designs of invertebrate eyes led me to study how visual systems squeeze real-time information into brains of limited capacity

The Man Group investigates the role of innate immunity in infectious diseases and cancer.

The Genomic Plasticity Lab studies how dynamic DNA structures and non-classical DNA modifications contribute to the formation and persistence of long-term memories, particularly in fear-related learning and memory.

The McCullough Group uses methods from machine learning and mathematics to study how the brain processes information and controls behaviour.

The main focus of our research group is to study red blood cells and platelets, exploring their roles in diseases, with projects available for students interested in immunology, parasitology, and human genetics.

Our lab studies a number of retinal diseases, with our main focus on finding novel diagnostics and treatment options for Age-Related Macular Degeneration (AMD).

CHOIR is the central point for early phase clinical research within the College of Health and Medicine.

Our group studies the mechanisms and transcriptome-wide patterns of eukaryotic mRNA translation and its regulation by RNA-binding proteins and non-coding RNA.

The Quinn Group's current research involves generating genetic models using Drosophila melanogaster to understand the initiation and progression of human cancer

The Schulte Group investigates therapy options arising from the nucleolar stress response.

Our main approach is to precisely define the types of rapid cell responses by analysing the gene-specific levels of translation.

The Soboleva Group studies mechanisms by which epigenetics controls cell differentiation and how those processes are affected in cancer.

Chromatin and transcriptional regulation during development

Our research interests are Immunity to virus infection and in particular CD8+ T cells, poxviruses and herpesviruses and antigen presentation.

My research has been focused on degenerative diseases of the retina, from the molecular and cellular level to the clinical.

The Wen Group focus on developing computational methods and models for RNA-mediated gene regulatory interactions to elucidate their impact on gene regulation, cellular identity, and the pathogenesis of diseases.